MFDS Files Complaint Against Namyang Dairy for Controversy Over 'Bulgari's COVID-19 Effect'

Namyang Dairy Products sparked controversy over the actual effectiveness after claiming that its fermented milk product 'Bulgari' has an inhibitory effect on the novel coronavirus infection (COVID-19). The photo shows Namyang Dairy Products' Bulgari being sold at a large supermarket in downtown Seoul on the 14th. (Photo by Yonhap News)

[Asia Economy Reporter Ryu Tae-min] The Ministry of Food and Drug Safety (MFDS) has decided to file a complaint against Namyang Dairy Products for violating the Food Labeling and Advertising Act after the company announced that its product has an effect in suppressing COVID-19, sparking controversy.

On the 15th, the MFDS announced that it plans to request administrative action from the local government in charge and file a complaint with the police regarding Namyang Dairy Products' announcement of the COVID-19 suppression effect of its 'Bulgari' product.

Earlier, on the 13th, Namyang Dairy Products announced at the 'Development of Antiviral Foods in the COVID-19 Era' symposium that it was the first in Korea to confirm the antiviral effect of its Bulgari fermented milk product against COVID-19.

An MFDS official explained the reason for the complaint, stating, "As a result of an urgent on-site investigation conducted that day, it was confirmed that Namyang Dairy Products actively participated in the research and the hosting of the symposium."

This content was produced with the assistance of AI translation services.